Global Synthetic Biology Market Analysis
According to Verified Market Intelligence, The Global Synthetic Biology Market was valued at USD 77.34 billion in 2017 and is projected to reach USD 127.76 billion by 2025, growing at a CAGR of 6.5% from 2018 to 2025.
What is Synthetic Biology?
Synthetic biology is defined as the field that combines biotechnology with the engineered techniques. It is used for designing and constructing new biological parts, devices, and systems as well as for re-designing of existing, natural biological systems for useful purposes. Synthetic biology involves combining of chemical synthesis of DNA with growing knowledge of genomics in order to allow the researchers to manufacture categorized DNA sequences and assemble them into new genomes. Increasing demand of novel medical procedures and increasing R&D funding contributes in the growth of synthetic biology market.
Global Synthetic Biology Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and Restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Increasing application of synthetic biology, growing demand for synthetic genes & cells, rise in investments in synthetic biology and growing popularity of organ on chip technology have been driving the global synthetic biology market. On the other hand, environmental concerns and safety issues might act as a restraint for the overall market at a global level.
Verified Market Intelligence narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The "Global Synthetic Biology Market" is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market. This can be of a great use in gaining knowledge about the cutting-edge technologies in the market.
Global Synthetic Biology Market Competitive Landscape
The "Global Synthetic Biology Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such Cargill, Archer Daniels Midland Company, Ingredion Incorporated, Tate & Lyle PLC, Agrana Beteiligungs-AG, Grain Processing Corporation, Roquette Frères, The Tereos Group, Royal Cosun, Altia Industrial Services, Grain Processing Corporation, Manildra Group, Universal Starch Chem Allied Ltd, GreenTech Industries Ltd, and AMYLCO Group of Companies. Cargill, ADM, Ingredion, and Tate & Lyle, Agrana. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above mentioned players globally.
Global Synthetic Biology Market Segmentation, by Tool and Technology
• Tool
o Oligonucleotides
o Enzymes
o Cloning Technology Kits
o Others
• Technology
o Gene Synthesis
o Next-Generation Sequencing
o Genome Engineering
o 3 Cloning and Sequencing
o Site-Directed Mutagenesis
o Others
Global Synthetic Biology Market Segmentation, by Application
• Medical Applications
o Pharmaceuticals
o Drug Discovery & Therapeutics
o Artificial Tissue and Tissue Regeneration
• Industrial Applications
o Biofuels & Renewable Energy
o Industrial Enzymes
o Biomaterials & Green Chemicals
• Food and Agriculture
• Environmental Applications
o Bioremediation
o Biosensing
Global Synthetic Biology Market Geographic Scope
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Rest of Asia Pacific
• Latin America
o Brazil
• Rest of the World
Research Methodology of Verified Market Intelligence:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Intelligence.
1 INTRODUCTION OF GLOBAL SYNTHETIC BIOLOGY MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL SYNTHETIC BIOLOGY MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL SYNTHETIC BIOLOGY MARKET, BY APPLICATION:
5.1 Overview
5.2 Medical Applications
5.2.1 Pharmaceuticals
5.2.2 Drug Discovery and Therapeutics
5.2.3 Artificial Tissue and Tissue Regeneration
5.3 Industrial Applications
5.3.1 Biofuel and Renewable Energy
5.3.2 Biomaterials and Green Chemicals
5.3.3 Industrial Enzymes
5.4 Food and Agriculture
5.5 Environmental Applications
5.5.1 Bioremediation
5.5.2 Bio sensing
6 GLOBAL SYNTHETIC BIOLOGY MARKET, BY TOOLS AND TECHNOLOGY:
6.1 Overview
6.2 Tool
6.2.1 Oligonucleotides
6.2.2 Enzymes
6.2.3 Cloning Technology Kits
6.2.4 Others
6.3 Technology
6.3.1 Gene Synthesis
6.3.2 Next-Generation Sequencing
6.3.3 Genome Engineering
6.3.4 3 Cloning and Sequencing
6.3.5 Site-Directed Mutagenesis
6.3.6 Others
7 GLOBAL SYNTHETIC BIOLOGY MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Argentina
7.6 Rest of the World
8 GLOBAL SYNTHETIC BIOLOGY MARKET COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Novozymes
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Merck KGaA
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Intrexon Corporation
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Agilent Technologies
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Amyris
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Genscript Biotech Corporation
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 Ginkgo Bioworks
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Integrated Dna Technologies (IDT)
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Development
9.10 New England Biolabs (NEB)
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Development
9.11 Synthetic Genomics
9.11.1 Overview
9.11.2 Financial Performance
9.11.3 Product Outlook
9.11.4 Key Development
9.12 Twist Bioscience
9.12.1 Overview
9.12.2 Financial Performance
9.12.3 Product Outlook
9.12.4 Key Development
10 Appendix
Related Reports
Price : US$ 3500 |
Date : Nov 2024 |
Category : Services |
Pages : 233 |
Price : US$ 3500 |
Date : Nov 2024 |
Category : Services |
Pages : 233 |